Latest BRAF Stories

2013-07-03 23:02:43

Mount Sinai dermatologists say skin cancer can be successfully treated if caught early. Aspen, CO (PRWEB) July 03, 2013 In an effort to detect and prevent skin cancer, dermatologists from The Mount Sinai Medical Center in New York City performed approximately 400 complimentary melanoma screenings at the Aspen Ideas Festival (AIF) in Aspen, Colorado. Mount Sinai is the first medical center to sponsor the AIF held from June 26 through July 2, 2013. The on-site screening team was led by...

2013-06-26 13:00:56

In 2 large studies, the association between aspirin use and risk of colorectal cancer was affected by mutation of the gene BRAF, with regular aspirin use associated with a lower risk of BRAF-wild-type colorectal cancer but not with risk of BRAF-mutated cancer, findings that suggest that BRAF-mutant colon tumor cells may be less sensitive to the effect of aspirin, according to a study in the June 26 issue of JAMA. Colorectal cancer is a leading cause of cancer-related death worldwide....

Melanoma Treatments Receive FDA Approval
2013-05-30 12:43:33

redOrbit Staff & Wire Reports - Your Universe Online The US Food and Drug Administration (FDA) has approved two new medicines used to treat the most dangerous form of skin cancer, as well as a genetic test developed alongside those drugs. The two new medications, both of which are manufactured by GlaxoSmithKline (GSK), are dabrafenib (which will be marketed as Tafinlar) and trametinib (which will be sold under the name Mekinist). They will be used to treat patients with advanced...

2013-04-11 10:42:26

For the first time, scientists have demonstrated the mechanism of action of gossypin, a naturally-occurring substance found in fruits and vegetables, as a treatment for melanoma, which causes the majority of deaths from skin cancer. "We identified gossypin as a novel agent with dual inhibitory activity towards two common mutations that are the ideal targets for melanoma treatment," said Texas Biomed's Hareesh Nair, Ph.D. At the moment, there is no single therapeutic agent or combination...

2013-04-10 13:33:05

Presence of the genetic mutation BRAF V600E was significantly associated with increased cancer-related death among patients with papillary thyroid cancer (PTC); however, because overall mortality in PTC is low and the association was not independent of tumor characteristics, how to use this information to manage mortality risk in patients with PTC is unclear, according to a study in the April 10 issue of JAMA, a Genomics theme issue. "Papillary thyroid cancer is the most common endocrine...

Word of the Day
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.